BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
Rhea-AI Summary
BD (NYSE: BDX) celebrated 65 years of manufacturing at its Broken Bow, Nebraska facility on Oct. 16, 2025. The site opened Oct. 18, 1960 and has grown from a 13,753-square-foot plant with 20 associates to a 310,000-square-foot facility employing nearly 600 associates.
Broken Bow is described as the world's largest manufacturer of BD Vacutainer® tubes, producing billions of tubes and other collection products annually. BD reports more than $50 million invested in Nebraska since 2020 and announced a separate >$35 million investment and 50 jobs at its Columbus facility. BD operates 30+ U.S. sites with ~10,000 employees.
Positive
- $50 million invested in Nebraska since 2020
- >$35 million new investment at Columbus facility
- 50 additional jobs to be created at Columbus
- Broken Bow facility expanded to 310,000 sq ft with ~600 associates
- Company operates 30+ U.S. manufacturing and distribution sites employing ~10,000
Negative
- None.
News Market Reaction – BDX
In the Oct 16 session, BDX declined 0.80%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Since opening its doors on Oct. 18, 1960, the
"For 65 years, our
Manufacturing Investments in
BD continues to invest in
As one of the largest
65th Anniversary Celebration
The 65th anniversary celebration ceremony in
BD is donating
About BD Vacutainer® products
BD Vacutainer® products are used to care for millions of patients around the world today to support high-quality specimen collection, patient comfort and health care provider safety. They are also helping to advance care for tomorrow, with BD Vacutainer® tubes used in more than 16,000 published clinical studies since 2018 alone.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
|
Contacts: |
|
|
Media: |
Investors: |
|
Fallon Mcloughlan |
Adam Reiffe |
|
BD Public Relations |
Vice President, Investor Relations |
|
201.258.0361 |
201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-looks-ahead-to-the-next-era-of-manufacturing-excellence-in-broken-bow-ne-and-celebrates-65-years-of-innovation-in-the-region-302586169.html
SOURCE BD (Becton, Dickinson and Company)